While the news on patients hospitalized with COVID-19 was not as hoped, the ability to positively impact outcomes when identified early is promising.
| less than a minute read
Multi-faceted approach to COVID-19: Eli Lilly Interview
Get in touch
Get in touch
Eli Lilly Chairman and CEO Dave Ricks told CNBC on Tuesday that he believes the company’s coronavirus antibody treatment will still be beneficial to Covid-19 patients, despite the recent end to a study of the drug in a hospital setting.
Get in touch
Get in touch
/Passle/5f6edd8e8cb62a0bec3e5fd2/SearchServiceImages/2024-02-29-16-58-20-525-65e0b7ac5e16e67d098d7631.jpg)
Characterized by the White House as “the most significant executive action any President has ever taken to protect Americans’ data...
/Passle/5f6edd8e8cb62a0bec3e5fd2/SearchServiceImages/2024-04-15-00-07-04-718-661c6fa8c2294b5a473c34e8.jpg)
/Passle/5f6edd8e8cb62a0bec3e5fd2/SearchServiceImages/2024-04-11-20-08-48-867-66184350107637cec4ac5dc2.jpg)